{
  "report_rows": [
    {
      "kpi": "Revenue",
      "prediction": "BEAT",
      "answer": "pred ~$1.24B vs. cons $1.21B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Non-GAAP EPS",
      "prediction": "BEAT",
      "answer": "pred ~$2.15 vs. cons $2.05",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Semiconductor Test revenue",
      "prediction": "BEAT",
      "answer": "pred ~$1.07B vs. cons $1.041B",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "3Q26 revenue guidance",
      "prediction": "LOWER",
      "answer": "guide ~$1.00B vs. cons $1.07B (3Q26)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "3Q26 non-GAAP EPS guidance",
      "prediction": "LOWER",
      "answer": "guide ~$1.52 vs. cons $1.70 (3Q26)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "1H26 share of FY26 revenue / second-half cadence",
      "prediction": "UNCHANGED",
      "answer": "guide ~58% vs. cons 58% (FY26 first-half revenue mix)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": -6.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -10.0,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "A Q2 revenue/EPS beat of ~$1.24B/$2.15 versus $1.21B/$2.05 is likely outweighed by implied out-period reductions from a ~$1.00B 3Q26 guide versus ~$1.07B consensus; the 5-day residual is ~-10.0% versus a day-1 residual of ~-6.5% as 3Q and FY27 estimates reset lower.",
  "day5_confidence": "MEDIUM"
}